Spring 2026 Health Policy and Management P8237 section 001

The Pharmaceutical Industry: Innovation,

Pharm Ind: Innv, Accss, &

Call Number 18070
Day & Time
Location
T 5:30pm-8:20pm
To be announced
Points 1.5
Grading Mode Standard
Approvals Required None
Type LECTURE
Method of Instruction In-Person
Course Description

This course provides a structured overview of the pharmaceutical industry, with a consistent lens on public health. While grounded in the U.S. system, the course will integrate global comparisons to highlight differences in regulation, pricing, and equity. Students will examine how medicines are developed, regulated, priced, marketed, and accessed, and will analyze the role of key stakeholders—including government, payers, advocacy groups, and industry. Through case studies, debates, and simulations, students will explore the ethical tensions that arise between innovation, affordability, and equity, and assess the impact of pharmaceutical decision-making on population health. In addition to building conceptual understanding, students will develop skills in policy analysis, stakeholder synthesis, and evidence-based communication through written memos, reflective essays, and structured in-class activities.

Web Site Vergil
Department Health Policy & Management
Enrollment 42 students (40 max) as of 9:07PM Monday, December 15, 2025
Status Full
Subject Health Policy and Management
Number P8237
Section 001
Division School of Public Health
Open To Public Health
Section key 20261HPMN8237P001